Advancements in Oncology
Advertisement
Dr. Manochakian discusses the implications of recent phase 3 trials in lung cancer.
Dr. Lopetegui-Lia reacts to Dr. Gatti-Mays' breast cancer panel discussion from Advancements in Oncology.
Dr. Margaret Gatti-Mays explains what makes The Oncology Brothers' content so important for community oncologists.
Dr. Margaret Gatti-Mays explains how to address the most pressing questions in triple-negative breast cancer treatments.
Dr. Gatti-Mays discusses how treatment for triple-negative breast cancer has evolved in recent years.
Dr. Manochakian discusses the most pressing unanswered questions in lung cancer and how they could be addressed.
Dr. Manochakian reflects on progress in lung cancer treatment and why it's critical to bring it to the community setting.
Dr. Margaret Gatti-Mays delves into the topic of HER2 tumor expression in breast cancer.
Dr. Gatti-Mays talks about the importance of tailoring treatments to individual patients with breast cancer.
Dr. Eng opines on how the ESOPEC study will alter the treatment paradigm for patients with esophageal/GEJ adenocarcinoma.
Dr. Eng comments on how she approaches treatment considerations and management for her younger patients with colon cancer.
Dr. Eng explains how she makes sense of the stage 4 third-line therapy options to administer to her colon cancer patients.
Dr. Eng shares what the COMMIT study suggest about colon cancer and this study's applicability outside of liver metastasis.
Dr. Manochakian shared his insights during the Oncology Brothers Advancements in Oncology event.
Dr. Eng provides her thoughts on ctDNA upfront, sequential, and combined with NGS testing for patients with colon cancer.
Dr. Rami Manochakian and The Oncology Brothers discusses treatment for SCLC, which is evolving at a rapid pace.
Dr. Manochakian discusses new data and why next-generation sequencing is a critical step when treating NSCLC.
Dr. Margaret Gatti-Mays, who specializes in breast cancer, delivers key insights on many breast cancer-related topics.
Dr. Ugurlu said the event was an inspiring experience that helped him navigate the latest data in oncology.
The Oncology Brothers and Dr. Manochakian discussed the rapid changes in the perioperative treatment landscape for NSCLC.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.